European Commission grants orphan drug status to Mylotarg for treatment of AML Nov. 16, 2000 No Comments
Potential cellular mechanism for adverse cardiac effects of Herceptin described at AHA sessions Nov. 16, 2000 No Comments
Independent safety board recommends continuation of Theratope vaccine phase III trial Nov. 15, 2000 No Comments
Data presented at Heat Shock Proteins symposium support clinical application of HspE7 Nov. 10, 2000 No Comments
RSS